GlassScriptPhysician profile
Richard M Levin
NPI 1760466486
$51,341.56
in general payments reported to CMS, 2019-2025
52 companies · $3,704 in 2025
The $3,704 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,827 · 2020: $19K · 2021: $7,702 · 2022: $5,456 · 2023: $3,723 · 2024: $1,909 · 2025: $3,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,086 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,059 · Travel and Lodging: $1,191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,085.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,059.29 |
| Travel and Lodging | $1,191.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $39,969.58 | 2019-2025 | Rezum Generator, Ams 700 Cxr Rte Kit, Greenlight Xps |
| Sn Holdings, LLC | $1,898.00 | 2023 | |
| Sumitomo Pharma America, INC. | $1,281.15 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $903.66 | 2019-2025 | Myrbetriq, Xtandi |
| Janssen Biotech, INC. | $783.81 | 2019-2025 | Erleada, Akeega |
| Abbvie INC. | $666.71 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $609.91 | 2022-2025 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $608.69 | 2021-2025 | |
| Antares Pharma, INC. | $490.72 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Coloplast Corp | $427.54 | 2021-2025 | Speedicath |
| Endo Pharmaceuticals INC. | $414.78 | 2019-2023 | Aveed, Xiaflex |
| Pfizer INC. | $330.94 | 2021-2025 | |
| Urovant Sciences INC | $303.03 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $202.88 | 2021-2025 | Prolaris |
| Novartis Pharmaceuticals Corporation | $199.78 | 2022-2025 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $185.80 | 2021-2022 | |
| Tolmar, INC. | $183.31 | 2023-2025 | Eligard, Jatenzo |
| Teleflex LLC | $178.27 | 2021-2022 | |
| Immunitybio, INC. | $164.27 | 2025 | |
| Urogen Pharma, INC. | $137.49 | 2022-2025 | |
| Tempus Ai, INC | $127.41 | 2024 | Xt Cdx |
| Medtronic, INC. | $125.77 | 2023-2024 | Interstim |
| Mission Pharmacal Company | $115.86 | 2022-2023 | Uribel |
| Tolmar Pharmaceuticals, INC. | $113.42 | 2021-2022 | |
| Endo USA, INC. | $88.79 | 2024-2025 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $85.46 | 2021-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Bioprotect Medical, INC. | $85.07 | 2025 | Bioprotect Balloon Implant System |
| Dendreon Pharmaceuticals LLC | $75.35 | 2021-2025 | Provenge |
| Allergan, INC. | $68.66 | 2019-2022 | |
| Telix Pharmaceuticals | $59.46 | 2022-2024 | Illuccix |
| Sun Pharmaceutical Industries INC. | $52.73 | 2019-2024 | |
| Olympus America INC. | $46.62 | 2023-2024 | Itind System |
| Accord Healthcare, INC. | $41.61 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $37.26 | 2022-2025 | Givlaari |
| Verity Pharmaceuticals INC. | $24.93 | 2025 | Tlando |
| Palette Life Sciences, INC. | $22.23 | 2022 | |
| Convatec INC. | $22.11 | 2021 | |
| Civco Medical Instruments | $20.05 | 2024 | |
| Clarus Therapeutics INC. | $19.98 | 2021 | |
| Blue Earth Diagnostics | $19.60 | 2021 | |
| Axonics, INC. | $18.30 | 2022 | |
| Halozyme INC | $17.88 | 2023 | |
| Travere Therapeutics, INC. | $17.36 | 2019 | |
| Abc Home Medical Supply, INC. | $17.14 | 2022 | |
| Valencia Technologies Corporation | $15.42 | 2025 | Ecoin Device Kit |
| Amgen INC. | $15.28 | 2023 | Prolia |
| Clovis Oncology, INC. | $14.54 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $13.95 | 2021 | |
| Foundation Medicine, INC. | $13.66 | 2022 | |
| Laborie Medical Technologies Corp. | $5.34 | 2025 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$361,837.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.